Glenmark Pharmaceuticals has introduced a new solution to address constipation with the launch of polyethylene glycol 3350 powder in the US market. The over-the-counter (OTC) medicine, similar in strength to MiraLAX’s 17 grams per capful treatment, marks a significant addition to available constipation treatments.
